chr15-22853374-CTT-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_030922.7(NIPA2):c.196+122_196+123del variant causes a intron change. The variant allele was found at a frequency of 0.152 in 373,554 control chromosomes in the GnomAD database, including 1,478 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.15 ( 1250 hom., cov: 23)
Exomes 𝑓: 0.15 ( 228 hom. )
Consequence
NIPA2
NM_030922.7 intron
NM_030922.7 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.79
Genes affected
NIPA2 (HGNC:17044): (NIPA magnesium transporter 2) This gene encodes a possible magnesium transporter. This gene is located adjacent to the imprinted domain in the Prader-Willi syndrome deletion region of chromosome 15. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 3, 7 and 21.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 15-22853374-CTT-C is Benign according to our data. Variant chr15-22853374-CTT-C is described in ClinVar as [Benign]. Clinvar id is 1260282.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.243 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NIPA2 | NM_030922.7 | c.196+122_196+123del | intron_variant | ENST00000337451.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NIPA2 | ENST00000337451.8 | c.196+122_196+123del | intron_variant | 5 | NM_030922.7 | P1 |
Frequencies
GnomAD3 genomes AF: 0.153 AC: 20913AN: 136808Hom.: 1242 Cov.: 23
GnomAD3 genomes
AF:
AC:
20913
AN:
136808
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.151 AC: 35818AN: 236718Hom.: 228 AF XY: 0.151 AC XY: 19346AN XY: 127868
GnomAD4 exome
AF:
AC:
35818
AN:
236718
Hom.:
AF XY:
AC XY:
19346
AN XY:
127868
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.153 AC: 20939AN: 136836Hom.: 1250 Cov.: 23 AF XY: 0.152 AC XY: 9982AN XY: 65774
GnomAD4 genome
AF:
AC:
20939
AN:
136836
Hom.:
Cov.:
23
AF XY:
AC XY:
9982
AN XY:
65774
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 13, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at